Gregory Fulcher
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nephrology top 5%
Papers in
-
- Diabetes Management and Research 21
- Diabetes Treatment and Management 11
- Diabetes Management and Education 7
- Surgery 10
- Pancreatic function and diabetes 6
- Co-authors
- E. G. Wilmshurst (3 shared papers)Mark Walker (8 shared papers)K. G. M. M. Alberti (5 shared papers)Carlo Catalano (6 shared papers)Bruce Neal (7 shared papers)Sophia Zoungas (10 shared papers)M. Farrer (6 shared papers)Dennis K. Yue (2 shared papers)
- Journals
- Diabetes Research and Clinical Practice (3 papers)Metabolism (3 papers)BMJ Open (3 papers)Scandinavian Journal of Clinical and Laboratory Investigation (3 papers)Diabetes (3 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Gregory Fulcher
73 papers receiving 2.3k citations
Gregory Fulcher's Hit Papers
Peers
Comparison fields: 5 of 115
- Endocrinology, Diabetes and Metabolism 1.2k
- Nephrology 144
- Physiology 294
- Surgery 430
- Clinical Biochemistry 60
Countries citing papers authored by Gregory Fulcher
This map shows the geographic impact of Gregory Fulcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Fulcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Fulcher more than expected).
Fields of papers citing papers by Gregory Fulcher
This network shows the impact of papers produced by Gregory Fulcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Fulcher. The network helps show where Gregory Fulcher may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory Fulcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes Hit paper breakdown → | 2017 | 319 |
| 2 | 2011 | 272 | |
| 3 | 2003 | 122 | |
| 4 | 2014 | 80 | |
| 5 | 2015 | 77 | |
| 6 | 2018 | 72 | |
| 7 | 2005 | 69 | |
| 8 | 1992 | 67 | |
| 9 | 1992 | 65 | |
| 10 | 2001 | 61 | |
| 11 | 2014 | 50 | |
| 12 | 2017 | 47 | |
| 13 | 2011 | 45 | |
| 14 | 2020 | 44 | |
| 15 | 2019 | 44 | |
| 16 | 2020 | 42 | |
| 17 | 1990 | 39 | |
| 18 | 2004 | 37 | |
| 19 | 2014 | 37 | |
| 20 | 2016 | 36 |
About Gregory Fulcher
Gregory Fulcher is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Physiology, Molecular Biology and Pathology and Forensic Medicine, having authored 75 papers that have together received 2.4k indexed citations. Recurring topics across this work include Diabetes Management and Research (21 papers), Diabetes Treatment and Management (11 papers), Diet and metabolism studies (7 papers), Adipose Tissue and Metabolism (7 papers), Diabetes Management and Education (7 papers), Pancreatic function and diabetes (6 papers), Muscle metabolism and nutrition (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Nephrology (144 citations), Physiology (294 citations), Surgery (430 citations) and Clinical Biochemistry (60 citations). Gregory Fulcher has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include E. G. Wilmshurst, Mark Walker, K. G. M. M. Alberti, Carlo Catalano, Bruce Neal, Sophia Zoungas, M. Farrer, Dennis K. Yue, Jonathan Thow and Emma Scott. Their work appears in journals such as Diabetes Research and Clinical Practice, Metabolism, BMJ Open, Scandinavian Journal of Clinical and Laboratory Investigation and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.